RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Marketable securities, non-current

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndMarketable securities, non-current (Million USD)YoY (%)
Dec 31, 20248,900+64.92%
Dec 31, 20235,397-18.13%
Dec 31, 20226,592-3.60%
Dec 31, 20216,838+118.08%
Dec 31, 20203,136-3.72%
Dec 31, 20193,257+85.57%
Dec 31, 20181,755+18.06%
Dec 31, 20171,486+72.00%
Dec 31, 2016864+36.71%
Dec 31, 2015632+37.38%
Dec 31, 2014460+18.02%
Dec 31, 2013390+43.75%
Dec 31, 2012271-1.69%
Dec 31, 2011276-25.45%
Dec 31, 2010370

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)